Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
NYU Langone Health
Age
55–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Left ventricular ejection fraction (LVEF) ≤ 40% within prior 6 months (any local measurement, made within the past 6 months using echocardiography, multigated acquisition (MUGA), computed tomography (CT) scanning, magnetic resonance imaging (MRI), or ventricular angiography is acceptable, provided no subsequent measurement above 40%)
Participants with multivessel CAD (defined as severe 3 vessel disease or 2 vessel disease including left anterior descending (LAD) artery disease) on coronary CT angiography (CCTA) or invasive coronary angiography
CAD amenable to either PCI or CABG as determined by the local heart team
Participant is willing to comply with all aspects of the protocol, including adherence to the assigned strategy, medical therapy and follow-up visits
Participant is able and willing to give written informed consent
You may not be if
Decompensated heart failure or cardiogenic shock in the past 48 hours prior to randomization
Concomitant significant valvular heart disease requiring surgery
Prior cardiac surgery
Dementia with loss of capacity to consent (clinically evident or previously diagnosed)
Stroke within the previous 6 months or spontaneous intracranial hemorrhage at any time
History of noncompliance with medical therapy
Life expectancy less than the duration of the trial due to non-cardiovascular comorbidity
Pregnancy (known to be pregnant; to be confirmed before randomization, if applicable)
Clareo Health | International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Left Ventricular Dysfunction Trial
